AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36157208 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy plus open radical hysterectomy (control group)
Number of subjects: 42
Study 34937547 — intervention group
Group type: EXPERIMENTAL
Intervention: Short DNA methylation telomere length (DNAmTL)
Number of subjects: 292
Study 34937547 — intervention group
Group type: EXPERIMENTAL
Intervention: DNAmTL age acceleration
Number of subjects: 292
Study 32151161 — intervention group
Group type: EXPERIMENTAL
Intervention: Culprit-lesion-only strategy
Number of subjects: 686
Study 32151161 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivessel percutaneous coronary intervention
Number of subjects: 686
Study 32151161 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison between sexes
Number of subjects: 686
Study 34998900 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (RT)
Number of subjects: 809
Study 34998900 — intervention group
Group type: COMPARATOR
Intervention: Palliative chemotherapy (CT)
Number of subjects: 809
Study 33186507 — intervention group
Group type: EXPERIMENTAL
Intervention: Video chat language samples
Number of subjects: 62
Study 33186507 — intervention group
Group type: COMPARATOR
Intervention: In-person language samples
Number of subjects: 62
Study 33186507 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcription reliability
Number of subjects: 62
Study 33198777 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel prognostic nomogram
Number of subjects: 32474
Study 34636899 — intervention group
Group type: EXPERIMENTAL
Intervention: Burosumab every 2 weeks (Q2W)
Number of subjects: 52
Study 34636899 — intervention group
Group type: COMPARATOR
Intervention: Burosumab every 4 weeks (Q4W)
Number of subjects: 52
Study 34636899 — intervention group
Group type: EXPERIMENTAL
Intervention: Burosumab therapy
Number of subjects: 52
Study 33872197 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus fish skin graft applied weekly for up to 12 weeks
Number of subjects: 49
Study 33872197 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) using collagen alginate dressing
Number of subjects: 49
Study 33872197 — intervention group
Group type: COMPARATOR
Intervention: SOC using collagen alginate dressing
Number of subjects: 49
Study 36151527 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance with abbreviated MRI
Number of subjects: 0
Study 36151527 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34509820 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified US FOTO model
Number of subjects: 1211
Study 34509820 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified UK National PROMs model
Number of subjects: 1211
Study 34509820 — intervention group
Group type: EXPERIMENTAL
Intervention: Keele Model 1
Number of subjects: 1211
Study 34509820 — intervention group
Group type: EXPERIMENTAL
Intervention: Keele Model 2
Number of subjects: 1211
Study 36182812 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS) paired with rehabilitation using the Vivistim® Paired VNS™ System
Number of subjects: 108
Study 33893673 — intervention group
Group type: EXPERIMENTAL
Intervention: Five telephone follow-up calls
Number of subjects: 52
Study 33893673 — intervention group
Group type: COMPARATOR
Intervention: No telephone calls (control)
Number of subjects: 52
Study 36173344 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan plus dapagliflozin
Number of subjects: 120
Study 36173344 — intervention group
Group type: COMPARATOR
Intervention: sacubitril/valsartan
Number of subjects: 120
Study 33410612 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypercapnia (Etco2 of 6.5 kPa)
Number of subjects: 19
Study 33410612 — intervention group
Group type: COMPARATOR
Intervention: Normocapnia (Etco2 of 5.5 kPa)
Number of subjects: 19
Study 33410612 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups pooled together
Number of subjects: 19
Study 32728703 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrase strand transfer inhibitor (InSTI) resistance testing
Number of subjects: 655
Study 32728703 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse transcriptase inhibitor and PI resistance testing
Number of subjects: 655
Study 36201186 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 386
Study 36201186 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting with supportive care (WWSC)
Number of subjects: 386
Study 36201186 — intervention group
Group type: EXPERIMENTAL
Intervention: Apnea-predominant OSA
Number of subjects: 386
Study 36201186 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypopnea-predominant OSA
Number of subjects: 386
Study 33609764 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualized Bone Reamer
Number of subjects: 80
Study 33609764 — intervention group
Group type: COMPARATOR
Intervention: Traditional Bone Reamer
Number of subjects: 80
Study 35659196 — intervention group
Group type: EXPERIMENTAL
Intervention: HomeHealth intervention
Number of subjects: 386
Study 35659196 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 386
Study 32389006 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive health education intervention program
Number of subjects: 80
Study 35947524 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (HDDT): amoxicillin 750 mg q.i.d. and esomeprazole 40 mg t.i.d.
Number of subjects: 216
Study 35947524 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin and clarithromycin-containing bismuth quadruple therapy (ACBQT): esomeprazole 20 mg, bismuth potassium citrate 2 g, amoxicillin 1 g, and clarithromycin 500 mg; b.i.d.
Number of subjects: 216
Study 36047662 — intervention group
Group type: EXPERIMENTAL
Intervention: Active HD-tDCS-eTBS
Number of subjects: 24
Study 36047662 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS-eTBS
Number of subjects: 24
Study 32277750 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy as an adjunct treatment for MUPS
Number of subjects: 0
Study 35131440 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CPAP treatment
Number of subjects: 98
Study 35131440 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP treatment
Number of subjects: 98
Study 33934522 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic AMU
Number of subjects: 322
Study 33934522 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic AMU
Number of subjects: 322
Study 35234097 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI + VMN
Number of subjects: 0
Study 35234097 — intervention group
Group type: EXPERIMENTAL
Intervention: pMDI + JN
Number of subjects: 0
Study 35234097 — intervention group
Group type: COMPARATOR
Intervention: VMN
Number of subjects: 0
Study 33960071 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) exercises, twice weekly for 8 weeks
Number of subjects: 45
Study 33960071 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 45
Study 34597919 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 34597919 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study 34597919 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 0
Study 34597919 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study 34597919 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab
Number of subjects: 0
Study 34597919 — intervention group
Group type: COMPARATOR
Intervention: Hydroxychloroquine/Chloroquine
Number of subjects: 0
Study 34244775 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacists' intention to report ADRs
Number of subjects: 188
Study 34244775 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude towards ADR reporting
Number of subjects: 188
Study 34244775 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective norm
Number of subjects: 188
Study 34244775 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived moral obligation
Number of subjects: 188
Study 33174467 — intervention group
Group type: EXPERIMENTAL
Intervention: CRMRF (448 kHz capacitive resistive monopolar radiofrequency)
Number of subjects: 45
Study 33174467 — intervention group
Group type: COMPARATOR
Intervention: CRMRF placebo
Number of subjects: 45
Study 33174467 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 45
Study 35622779 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidized regenerated cellulose (SurgiGuard®) plus closed suction drainage
Number of subjects: 94
Study 35622779 — intervention group
Group type: COMPARATOR
Intervention: Closed suction drainage alone
Number of subjects: 94
Study 33952876 — intervention group
Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 74
Study 33952876 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 74
Study 35152534 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI prognostic score based on serum CA19-9 and three MRI findings (tumour multiplicity, lymph node metastasis, bile duct invasion)
Number of subjects: 316
Study 35152534 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI prognostic score
Number of subjects: 316
Study 33528862 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitrous oxide (INO)
Number of subjects: 314
Study 33528862 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine
Number of subjects: 314
Study 33528862 — intervention group
Group type: COMPARATOR
Intervention: No analgesic
Number of subjects: 314
Study 35641925 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation induction video delivered via VR headset during teeth cleaning, brochure about EBTs, and a 4-week text message program
Number of subjects: 376
Study 35641925 — intervention group
Group type: COMPARATOR
Intervention: Relaxation video delivered via VR headset during teeth cleaning, the same brochure as INT, and assessment-only text messages
Number of subjects: 376
Study 35641925 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation induction video delivered via VR headset
Number of subjects: 376
Study 35641925 — intervention group
Group type: COMPARATOR
Intervention: Relaxation video delivered via VR headset
Number of subjects: 376
Study 33464990 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychological constructs
Number of subjects: 276
Study 33464990 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of a core set of psychological outcomes
Number of subjects: 276
Study 33464990 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trials
Number of subjects: 276
Study 32534515 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Migraine (CM) patients
Number of subjects: 71
Study 32534515 — intervention group
Group type: EXPERIMENTAL
Intervention: Episodic Migraine (EM) patients
Number of subjects: 71
Study 32534515 — intervention group
Group type: COMPARATOR
Intervention: Headache-free controls
Number of subjects: 71
Study 32534515 — intervention group
Group type: EXPERIMENTAL
Intervention: All migraine patients (CM and EM)
Number of subjects: 71
Study 36818483 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized milrinone
Number of subjects: 32
Study 36818483 — intervention group
Group type: COMPARATOR
Intervention: IV milrinone
Number of subjects: 32
Study 33004727 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Motivational Therapy (GMT)
Number of subjects: 108
Study 33004727 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised Motivational Therapy (IMT)
Number of subjects: 108
Study 33004727 — intervention group
Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 108
Study 36284336 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensemble algorithm for identifying CRT reports
Number of subjects: 5000
Study 36284336 — intervention group
Group type: COMPARATOR
Intervention: Individual algorithms (SVM and CNN)
Number of subjects: 5000
Study 32467406 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative consultations
Number of subjects: 400
Study 32467406 — intervention group
Group type: EXPERIMENTAL
Intervention: Floating hospice referrals
Number of subjects: 400
Study 32467406 — intervention group
Group type: EXPERIMENTAL
Intervention: Floating hospice discharge
Number of subjects: 400
Study 32467406 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care consults
Number of subjects: 400
Study 35044272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosyntropin
Number of subjects: 34
Study 35044272 — intervention group
Group type: COMPARATOR
Intervention: Vigabatrin
Number of subjects: 34
Study 35044272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosyntropin and Vigabatrin combined
Number of subjects: 34
Study 34540188 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 ?g/kg loading dose for 15 min, followed by 0.4 ?g/kg/h until 30 min before surgery)
Number of subjects: 174
Study 34540188 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline administered in the same manner)
Number of subjects: 174
Study 33605677 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent+HIFUA
Number of subjects: 92
Study 33605677 — intervention group
Group type: COMPARATOR
Intervention: Stent-only
Number of subjects: 92
Study 35461788 — intervention group
Group type: EXPERIMENTAL
Intervention: Early bedtime condition (9.5 hours sleep opportunity)
Number of subjects: 90
Study 35461788 — intervention group
Group type: COMPARATOR
Intervention: Late bedtime condition (6.5 hours sleep opportunity)
Number of subjects: 90
Study 33851255 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic HA filler (Sardenyashape®)
Number of subjects: 96
Study 33851255 — intervention group
Group type: COMPARATOR
Intervention: Biphasic HA filler (Restylane LYFT®)
Number of subjects: 96
Study 34406530 — intervention group
Group type: EXPERIMENTAL
Intervention: Early allopurinol initiation (day 1)
Number of subjects: 117
Study 34406530 — intervention group
Group type: COMPARATOR
Intervention: Late allopurinol initiation (day 14)
Number of subjects: 117
Study 33002598 — intervention group
Group type: EXPERIMENTAL
Intervention: NU-HOME program (family meals-focused program)
Number of subjects: 114
Study 33002598 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 114
Study 32734691 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 692
Study 32734691 — intervention group
Group type: COMPARATOR
Intervention: High-fat diet
Number of subjects: 692
Study 35611683 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 19
Study 35611683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 34256819 — intervention group
Group type: EXPERIMENTAL
Intervention: CPX-351
Number of subjects: 309
Study 34256819 — intervention group
Group type: COMPARATOR
Intervention: 7 + 3
Number of subjects: 309
Study 36361239 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop test (15 min, 600 tasks, 5 colors)
Number of subjects: 64
Study 34407724 — intervention group
Group type: EXPERIMENTAL
Intervention: Father-child dyads
Number of subjects: 29
Study 34407724 — intervention group
Group type: COMPARATOR
Intervention: Control dyads (randomly paired signals)
Number of subjects: 29
Study 34330857 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions with a trained social worker, 4-5 sessions over approximately 4 weeks.
Number of subjects: 16
Study 33155754 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)
Number of subjects: 771
Study 33155754 — intervention group
Group type: COMPARATOR
Intervention: BEACOPP escalated plus BEACOPP baseline (4 + 4 courses)
Number of subjects: 771
Study 33155754 — intervention group
Group type: COMPARATOR
Intervention: BEACOPP escalated plus BEACOPP baseline (4 + 4) and Rituximab
Number of subjects: 771
Study 35831176 — intervention group
Group type: EXPERIMENTAL
Intervention: IVT+EVT
Number of subjects: 539
Study 35831176 — intervention group
Group type: COMPARATOR
Intervention: EVT alone
Number of subjects: 539
Study 34680123 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA) adjunctive therapy (16 mg/mL cross-linked and 2 mg/mL non-cross-linked)
Number of subjects: 0
Study 34680123 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-surgical periodontal therapy without HA)
Number of subjects: 0
Study 34391978 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telemedicine (HBT) delivery of Prolonged Exposure (PE)
Number of subjects: 136
Study 34391978 — intervention group
Group type: COMPARATOR
Intervention: In-person delivery of Prolonged Exposure (PE)
Number of subjects: 136
Study 32483134 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (single 80-mg oral dose)
Number of subjects: 60
Study 34229675 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills and self-efficacy training for healthcare workers (4 sessions of 90 minutes each)
Number of subjects: 105
Study 34229675 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills and self-efficacy training for healthcare workers
Number of subjects: 105
Study 35457480 — intervention group
Group type: EXPERIMENTAL
Intervention: SST + TPE
Number of subjects: 157
Study 35457480 — intervention group
Group type: COMPARATOR
Intervention: SST
Number of subjects: 157
Study 32304405 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (50 mg/kg loading dose for 15 min, followed by 15 mg · kg · h infusion)
Number of subjects: 120
Study 32304405 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 120
Study 32304405 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 120
Study 33570279 — intervention group
Group type: EXPERIMENTAL
Intervention: Error management trainings
Number of subjects: 656
Study 33570279 — intervention group
Group type: COMPARATOR
Intervention: Missing trainings on error management
Number of subjects: 656
Study 33570279 — intervention group
Group type: COMPARATOR
Intervention: Documentation errors
Number of subjects: 656
Study 33079884 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (0.1 mg/kg initial dose, adjusted by 10% based on analgesia adequacy)
Number of subjects: 113
Study 35384093 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal oral intake immediately after discharge from PACU
Number of subjects: 174
Study 35384093 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral intake 6 hours after discharge from PACU
Number of subjects: 174
Study 35384093 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal oral intake
Number of subjects: 174
Study 35384093 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral intake
Number of subjects: 174
Study 35384093 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 174
Study 33901689 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 % Nisin with MTAD
Number of subjects: 40
Study 33901689 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3 % NaOCl and MTAD
Number of subjects: 40
Study 33901689 — intervention group
Group type: COMPARATOR
Intervention: 2.5 % NaOCl and 17 % EDTA
Number of subjects: 40
Study 33901689 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with MTAD
Number of subjects: 40
Study 32555601 — intervention group
Group type: EXPERIMENTAL
Intervention: True-immunized (n=21) with 810-1235 infected bites
Number of subjects: 26
Study 32555601 — intervention group
Group type: COMPARATOR
Intervention: Mock-immunized (n=5)
Number of subjects: 26
Study 32555601 — intervention group
Group type: EXPERIMENTAL
Intervention: True-immunized (n=10) with 839-1131 infected bites in Cohort 2
Number of subjects: 26
Study 32555601 — intervention group
Group type: COMPARATOR
Intervention: Mock-immunized (n=2) in Cohort 2
Number of subjects: 26
Study 32555601 — intervention group
Group type: EXPERIMENTAL
Intervention: True-immunized subjects administered three booster immunizations
Number of subjects: 26
Study 32555601 — intervention group
Group type: COMPARATOR
Intervention: Controls (n=6)
Number of subjects: 26
Study 36372813 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand removal (ODR) of syndesmotic screws
Number of subjects: 0
Study 36372813 — intervention group
Group type: COMPARATOR
Intervention: Routine removal (RR) of syndesmotic screws
Number of subjects: 0
Study 33143639 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinstalled nasopharyngeal airway (NPA) in the right nasal passageway
Number of subjects: 108
Study 33143639 — intervention group
Group type: COMPARATOR
Intervention: NGI via the right nostril (Group O)
Number of subjects: 108
Study 33977796 — intervention group
Group type: EXPERIMENTAL
Intervention: Anifrolumab (300 mg every 4 weeks for 48 weeks)
Number of subjects: 726
Study 33977796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study 35599520 — intervention group
Group type: EXPERIMENTAL
Intervention: Osseo-densification technique using specialized (Densah) bur kit
Number of subjects: 20
Study 35599520 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique using standard bur kit
Number of subjects: 20
Study 32116251 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically DBP levels (per 1 standard deviation (SD) increase 50 mg/L)
Number of subjects: 0
Study 34873082 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical intervention for PCOS management over 3 months
Number of subjects: 117
Study 34873082 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical intervention for PCOS management at 2 months
Number of subjects: 117
Study 33717194 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika purified-inactivated virus (ZPIV) vaccine, 3 doses
Number of subjects: 0
Study 33717194 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika purified-inactivated virus (ZPIV) vaccine in JEV pre-immunized individuals
Number of subjects: 0
Study 33717194 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika purified-inactivated virus (ZPIV) vaccine in YFV pre-immunized individuals
Number of subjects: 0
Study 33717194 — intervention group
Group type: EXPERIMENTAL
Intervention: Zika purified-inactivated virus (ZPIV) vaccine in flavivirus-naïve individuals
Number of subjects: 0
Study 35490585 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided stellate ganglion injection
Number of subjects: 68
Study 35490585 — intervention group
Group type: COMPARATOR
Intervention: Conventional blind puncture block
Number of subjects: 68
Study 34794202 — intervention group
Group type: EXPERIMENTAL
Intervention: CitruSlim high-dose (HD, 400 mg)
Number of subjects: 97